Metabolomic data of H460 and A549 cells after trametinib treatment

Published: 1 March 2022| Version 1 | DOI: 10.17632/54xr9bsxd2.1
Contributor:
zhengke lian

Description

MAP kinse-ERK kinase inhibitor (MEKi) resistance remains unknown. We determined gene expression profiling in MEKi-resistant cells and MEKi-sensitive cells after MEKi treatment using UHPLC-MS/MS.

Files

Institutions

East China Normal University

Categories

Oncology, Metabolomics, Drug Resistance

Licence